Status:
UNKNOWN
Gut Microbiota and Color-rectal Cancer.
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Collaborating Sponsors:
Reina Sofia University Hospital
Junta de Andalucia
Conditions:
Cancer
Colo-rectal Cancer
Eligibility:
All Genders
50-69 years
Brief Summary
This clinical trial is focused in the development of a screening test for the people at risk of colo-rectal cancer (aged more than 50 years old), valid and safe, improving the screening prognosis incr...
Detailed Description
Colo-rectal cancer (CCR) is one of the most prevalent cancers in developed countries. Several studies suggest that the CCR may be related with changes in the gut microbiota. This clinical trial is foc...
Eligibility Criteria
Inclusion
- Patients with positive results in the fecal occult blood test in the Program for Early Detection of Colon and Rectal Cancer, undergone by the Consejeria de Salud de la Junta de Andalucia (Spain).
Exclusion
- The consumption of antibiotic within the previous month to inclusion in the study.
Key Trial Info
Start Date :
January 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04662853
Start Date
January 17 2017
End Date
July 31 2021
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reina Sofia University Hospital
Córdoba, Cordoba, Spain, 14004